130 related articles for article (PubMed ID: 34929555)
1. Relationship between immunometabolic status and cognitive performance among major depression disorder patients.
Sánchez-Carro Y; de la Torre-Luque A; Portella MJ; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Peretó M; Toll A; Martínez-Ruiz A; Ferreiros-Martinez R; Álvarez P; Soria V; López-García P
Psychoneuroendocrinology; 2022 Mar; 137():105631. PubMed ID: 34929555
[TBL] [Abstract][Full Text] [Related]
2. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder.
Sánchez-Carro Y; Portella MJ; Leal-Leturia I; Salvat-Pujol N; Etxandi M; de Arriba-Arnau A; Urretavizcaya M; Pousa E; Toll A; Álvarez P; Soria V; López-García P
J Affect Disord; 2021 Jan; 279():343-352. PubMed ID: 33099048
[TBL] [Abstract][Full Text] [Related]
3. Serum calcium levels and neuropsychological performance in depression and matched healthy controls: Reversal of correlation a marker of the aging cognitive clock?
Grützner TM; Listunova L; Fabian GA; Kramer BA; Flach D; Weisbrod M; Roesch-Ely D; Sharma A
Psychoneuroendocrinology; 2018 May; 91():198-205. PubMed ID: 29587243
[TBL] [Abstract][Full Text] [Related]
4. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning.
Sánchez-Carro Y; de la Torre-Luque A; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Pérez-Solà V; Toll A; Martínez-Ruiz A; Ferreirós-Martínez R; Pérez S; Sastre J; Álvarez P; Soria V; López-García P
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110674. PubMed ID: 36332700
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls.
Bo Q; Dong F; Li X; Li F; Li P; Yu H; He F; Zhang G; Wang Z; Ma X; Wang C
Psychiatry Clin Neurosci; 2019 Feb; 73(2):70-76. PubMed ID: 30393945
[TBL] [Abstract][Full Text] [Related]
7. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
[TBL] [Abstract][Full Text] [Related]
10. Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression.
Jin K; Lu J; Yu Z; Shen Z; Li H; Mou T; Xu Y; Huang M
J Affect Disord; 2020 Dec; 277():204-211. PubMed ID: 32829196
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Profile and Relationship with Quality of Life and Psychosocial Functioning in Mood Disorders.
Zazula R; Mohebbi M; Dodd S; Dean OM; Berk M; Vargas HO; Nunes SOV
Arch Clin Neuropsychol; 2022 Feb; 37(2):376-389. PubMed ID: 34259318
[TBL] [Abstract][Full Text] [Related]
12. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
[TBL] [Abstract][Full Text] [Related]
13. Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.
Liu T; Zhong S; Wang B; Liao X; Lai S; Jia Y
J Affect Disord; 2019 Jan; 243():55-61. PubMed ID: 30227315
[TBL] [Abstract][Full Text] [Related]
14. Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study.
Srisurapanont M; Mok YM; Yang YK; Chan HN; Della CD; Zainal NZ; Jambunathan S; Amir N; Kalita P
J Affect Disord; 2018 May; 232():237-242. PubMed ID: 29499506
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Performance in First-Degree Relatives of Individuals With vs Without Major Depressive Disorder: A Meta-analysis.
MacKenzie LE; Uher R; Pavlova B
JAMA Psychiatry; 2019 Mar; 76(3):297-305. PubMed ID: 30586133
[TBL] [Abstract][Full Text] [Related]
16. Immune gene co-expression signatures implicated in occurence and persistence of cognitive dysfunction in depression.
Zang JCS; Hohoff C; Van Assche E; Lange P; Kraft M; Sandmann S; Varghese J; Jörgens S; Knight MJ; Baune BT
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110826. PubMed ID: 37451594
[TBL] [Abstract][Full Text] [Related]
17. Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.
Niemegeers P; de Boer P; Schuermans J; Dumont GJH; Coppens V; Spittaels K; Claes S; Sabbe BGC; Morrens M
J Affect Disord; 2019 Feb; 245():356-363. PubMed ID: 30423462
[TBL] [Abstract][Full Text] [Related]
18. Multidimensional cognitive impairment in unipolar and bipolar depression and the moderator effect of adverse childhood experiences.
Poletti S; Aggio V; Brioschi S; Dallaspezia S; Colombo C; Benedetti F
Psychiatry Clin Neurosci; 2017 May; 71(5):309-317. PubMed ID: 28004481
[TBL] [Abstract][Full Text] [Related]
19. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
Chakrabarty T; Harkness KL; McInerney SJ; Quilty LC; Milev RV; Kennedy SH; Frey BN; MacQueen GM; Müller DJ; Rotzinger S; Uher R; Lam RW
Psychol Med; 2020 Nov; 50(15):2536-2547. PubMed ID: 31583989
[TBL] [Abstract][Full Text] [Related]
20. Influence of comorbid anxiety symptoms on cognitive deficits in patients with major depressive disorder.
Liu J; Dong Q; Lu X; Sun J; Zhang L; Wang M; Liu B; Ju Y; Wan P; Guo H; Zhao F; Zhang X; Zhang Y; Li L
J Affect Disord; 2020 Jan; 260():91-96. PubMed ID: 31493645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
